The final deadline to submit the abstract(s) is February 23 , 2020. Abstracts will not be able to be submitted online after this date. The submitting author will receive notification of acceptance on April 19, 2021. At the time of the confirmation of acceptance of your abstract, presenters will be requested to register for the congress. Deadline for abstract confirmation of acceptance and presenter registration on May 31, 2021.
|November 2, 2020||Abstract Submission Opens|
|February 23, 2021||Abstract Submission Deadline|
|April 19, 2021||Communication to submitters on approved / rejected abstracts|
|May 31, 2021||Deadline for presenter registration|
Choosing a Topic
During the submission process, you will be asked to select the topic for your abstract. The topic is the general heading under which the abstract will be reviewed and later published in the congress materials, if accepted. The topic which best describes the subject of the abstract should be chosen. IPTA reserves the right to reassign the topic of the abstract for the purposes of programming.
All abstracts should be formatted into the following four sections:
All abstracts must be submitted electronically through the Congress abstract submission website.
Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.
IPTA welcomes the submission of abstracts that have been presented previously at regional, national, or international meetings in the two years since the last IPTA Congress (2019) given the highly specialized nature of pediatric solid organ transplantation and related themes. However, if a manuscript of the abstract has been published, submission will not be permitted.
IPTA regards plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author are rejected. In addition, the submitting author’s profile and scholarship application, in the case one has been submitted, will also be cancelled.
To be eligible to submit an abstract, you must disclose that the authors/ scientists have not violated any aspect of The Transplantation Society Ethics statements and that this research conforms with the ethical statements noted.
Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the following policy documents:
The IPTA 2021 Scientific Advisory Committee may require further information on the ethical aspects when evaluating the abstracts.
Format of Presentation
You may opt to submit your abstract to be considered for an oral presentation, a poster presentation, or either (at the committee’s discretion).
Notification of Acceptance or Rejection to Corresponding Author
Notification of acceptance or rejection will be sent to the submitting (corresponding) author by April 19, 2021. Please note that only the corresponding author will receive the communication concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.
Rule of Two
Each presenting author may present a maximum of two abstracts during the entire Congress (oral, mini-orals or posters). The number of submissions is however not limited. Should an author have more than two abstracts accepted for presentation, a co-author must be named as presenter for one or more abstracts.